June 2015
Volume 56, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2015
Safety and toxicity of a preservative free azithromycin/dexamethasone fixed combination in rabbit eyes
Author Affiliations & Notes
  • Yussett Contreras
    Medical Management, Laboratorios Sophia S.A. de C.V., Zapopan, Mexico
  • Leopoldo Martin Baiza-Duran
    Medical Management, Laboratorios Sophia S.A. de C.V., Zapopan, Mexico
  • Oscar Olvera Montaño
    Medical Management, Laboratorios Sophia S.A. de C.V., Zapopan, Mexico
  • Paloma Marquez
    Medical Management, Laboratorios Sophia S.A. de C.V., Zapopan, Mexico
  • Juan D Quintana-Hau
    Pharmaceutical Development, Laboratorios Sophia S.A. de C.V., Zapopan, Mexico
  • Humberto Figueroa
    Pharmaceutical Development, Laboratorios Sophia S.A. de C.V., Zapopan, Mexico
  • Gloria Aviña
    Pharmaceutical Development, Laboratorios Sophia S.A. de C.V., Zapopan, Mexico
  • Footnotes
    Commercial Relationships Yussett Contreras, Laboratorios Sophia S.A. de C.V. (E); Leopoldo Baiza-Duran, Laboratorios Sophia S.A. de C.V. (E); Oscar Olvera Montaño, Laboratorios Sophia S.A. de C.V. (E); Paloma Marquez, Laboratorios Sophia S.A. de C.V. (E); Juan Quintana-Hau, Laboratorios Sophia S.A. de C.V. (E); Humberto Figueroa, Laboratorios Sophia S.A. de C.V. (E); Gloria Aviña, Laboratorios Sophia S.A. de C.V. (E)
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2015, Vol.56, 694. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Yussett Contreras, Leopoldo Martin Baiza-Duran, Oscar Olvera Montaño, Paloma Marquez, Juan D Quintana-Hau, Humberto Figueroa, Gloria Aviña; Safety and toxicity of a preservative free azithromycin/dexamethasone fixed combination in rabbit eyes. Invest. Ophthalmol. Vis. Sci. 2015;56(7 ):694.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: To evaluate clinical and histopathological safety and toxicity of preservative free azithromycin /dexamethasone ophthalmic solution (AZi/DX) in rabbit eyes.

Methods: Thirty healthy New Zealand White rabbits were included in this study. Doses were given 4 times a day for 30 days. Slit lamp examination, fluorescein and lissamine green staining were performed on days 2, 5, 10, 15, 20, 25 and 30; additionally intraocular pressure (IOP) was measured on days 15, 20, 25 and 30. On day 31 rabbits were euthanized and eyes enucleated for histopathological assessment. Conjunctival hyperemia, chemosis, corneal staining, conjunctival discharge and IOP were assessed as clinical toxicity and safety criteria.

Results: Compared with baseline, hyperemia was the only variable that showed statistically significant changes during visits, nonetheless, was rated as minimal or mild. No increase in IOP was found. In the histopathological report there were no signs of cellular toxicity.

Conclusions: Conjunctival hyperemia is a nonspecific sign of toxicity, especially when considering it is unrelated to any other finding, including histopathological evaluations. Thus we can conclude AZi/DX it is safe when applied in rabbit eyes.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×